The US Food and Drug Administration has announced the recall of approximately 90,000 bottles of Children’s Ibuprofen Oral Suspension due to potential contamination with foreign material. Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert following notification of the recall by Strides Pharma Inc.
Key takeaways
- 90,000 bottles of Children’s Ibuprofen Oral Suspension recalled due to foreign material contamination
- Strides Pharma Inc. initiated voluntary recall after FDA notification
- NAFDAC alerts Nigerian consumers despite no direct distribution to Nigeria
Recall Details and Product Information
According to NAFDAC’s public alert, the recalled product is Children’s Ibuprofen Oral Suspension, USP (100 mg/5 mL) manufactured by Strides Pharma Inc. The FDA identified the presence of foreign material in the suspension as the primary reason for the voluntary recall.
The recall affects bottles distributed in the United States market. NAFDAC emphasized that while the product is not directly distributed in Nigeria, Nigerian consumers who may have obtained the product through international purchases should be aware of the safety alert. For more information on pharmacy and prescribing safety, healthcare professionals should stay updated on international drug recalls.
Safety Implications for Pediatric Medication
Foreign material contamination in pediatric medications poses particular risks for children, who may be more susceptible to adverse effects. The World Health Organization has consistently emphasized the importance of pharmaceutical quality control, especially for pediatric formulations.
Healthcare professionals should advise parents to check ibuprofen products for any visible foreign particles before administration. The recall highlights the critical importance of robust quality assurance systems in pharmaceutical manufacturing. Additional information on quality and safety standards can help healthcare providers understand regulatory oversight mechanisms.
Approximately 90,000 bottles of Children’s Ibuprofen Oral Suspension have been recalled due to potential contamination with foreign material
— US Food and Drug Administration (Public Alert, 2026)
What this means
Frequently asked questions
What should parents do if they have the recalled ibuprofen?
Parents should immediately stop using the product and consult their healthcare provider. Any adverse effects should be reported to local drug regulatory authorities.
How can consumers identify the recalled product?
The recalled product is Children’s Ibuprofen Oral Suspension, USP (100 mg/5 mL) manufactured by Strides Pharma Inc. Specific lot numbers should be checked against FDA recall notices.
Are other ibuprofen products affected?
This recall is specific to the Children’s Ibuprofen Oral Suspension from Strides Pharma Inc. Other ibuprofen products from different manufacturers are not affected by this particular recall.
The recall underscores the importance of robust international pharmaceutical safety monitoring systems. NAFDAC’s proactive alert demonstrates effective regulatory cooperation in protecting public health, even when products are not directly distributed domestically. Continued vigilance in pharmaceutical quality control remains essential for pediatric medication safety worldwide.
Source: NAFDAC Public Alert No. 028/2026
Was this article helpful?
Related Coverage
